BHV-2100 is under clinical development by Biohaven and currently in Phase II for Neuropathic Pain (Neuralgia).

A single-center retrospective study in China found a significant association between pain duration and intensity in patients ...

Pain management has seen a profound transformation in recent years, driven by advancements in regenerative medicine and ...

ANP-390 is under clinical development by AlphaNavi Pharma and currently in Phase I for Peripheral Neuropathic Pain.

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...

On Power Athlete Radio Episode 745, Dr. Adeel Khan shed light on the pitfalls of conventional pain management options and emphasized the transformative potentia ...

Professor Kim Jung-soo of the Department of Anesthesiology Pain Medicine at Seoul National University Hospital won the '2024 ...

Some of the most commonly-prescribed analgesic medications for dogs include Amantadine, which controls the pain response by antagonizing receptors in the central nervous system, and is used in ...

Cellular research indicates that neuropilin-1 plays a crucial role in pain signaling, presenting a potential pathway for ...

Neuropathic Pain Drugs Found to Increase Risk of Hip Fracture in Older Adults Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to ...

New Delhi: Rahi Sarnobat recalls that autumn day of 2022 with clarity. Indian shooters, following a medalless Tokyo Olympics ...